Paranovus Entertainment Technology Ltd
NASDAQ:PAVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Paranovus Entertainment Technology Ltd
Total Equity
Paranovus Entertainment Technology Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Paranovus Entertainment Technology Ltd
NASDAQ:PAVS
|
Total Equity
$23.6m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen Breo Technology Co Ltd
SSE:688793
|
Total Equity
¥370m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
D
|
Dencare Chongqing Oral Care Co Ltd
SZSE:001328
|
Total Equity
¥1.5B
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Minsheng Healthcare Co Ltd
SZSE:301507
|
Total Equity
¥1.5B
|
CAGR 3-Years
44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
M
|
Mao Geping Cosmetics Co Ltd
HKEX:1318
|
Total Equity
¥4.7B
|
CAGR 3-Years
60%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Runben Biotechnology Co Ltd
SSE:603193
|
Total Equity
¥2.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Paranovus Entertainment Technology Ltd
Glance View
Paranovus Entertainment Technology Ltd. engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company is headquartered in Nanping, Fujian and currently employs 218 full-time employees. The company went IPO on 2019-10-25. The firm's main businesses are the research and development, manufacturing and sales of nutritional products made from traditional Chinese medicine and animal extracts. The firm's main products include spore powder, cordyceps mycelium products, donkey-hide gelatin solution products, vitamins and dietary supplement products, American ginseng products and other nutrition products. The firm also engages in e-commerce and auto sales through the platforms Happy Buy and Taochejun.
See Also
What is Paranovus Entertainment Technology Ltd's Total Equity?
Total Equity
23.6m
USD
Based on the financial report for Sep 30, 2025, Paranovus Entertainment Technology Ltd's Total Equity amounts to 23.6m USD.
What is Paranovus Entertainment Technology Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
-19%
Over the last year, the Total Equity growth was -21%. The average annual Total Equity growth rates for Paranovus Entertainment Technology Ltd have been -24% over the past three years , -19% over the past five years .
